Precision BioSciences(DTIL) Stock Price Today

$Precision BioSciences (DTIL.US)$
The initial results from Precision BioSciences' ELIMINATE-B trial represent a significant breakthrough in gene editing therapeutics for chronic Hepatitis B. The demonstration of both safety and efficacy signals at the lowest dose level (0.2 mg/kg) is particularly noteworthy for several reasons:
The safety profile is remarkably clean, with no Grade ≥2 treatment-related adverse events or serious adverse events reported. This is important ...

Teddy123

Feb 19 06:18

Precision BioSciences Announces Initial Safety and Antiviral Activity of PBGENE-HBV in the ELIMINATE-B Clinical Trial

$Precision BioSciences (DTIL.US)$
Revolutionary Gene Therapy Achieves First-Ever ARCUS Success Against Hepatitis B - What's Next?

Trytosaveabit

Feb 19 06:04

news

$Precision BioSciences (DTIL.US)$ Reuters· 2 mins ago
Precision BioSciences Announces Initial Safety and Antiviral Activity of Pbgene-Hbv in the Eliminate-B Clinical Trial

Jaguar8

Feb 18 22:22

🔵Watchlist, FEBRUARY 19,2025, Wednesday. NFA - DrJag8

NOTE!
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY...

119

DTIL Precision BioSciences

Trade Overview

Capital Trend

News

Comments

Trending Stocks